Groundbreaking Yet Controversial Alzheimer’s Drug Administered to First Patient
It could be a game-changer for treating Alzheimer’s, but not all are convinced.
Veuer’s Tony Spitz has the details.
First patient receives Biogen Alzheimer's drugA U.S. hospital on Wednesday gave the first infusion of an expensive, controversial new Alzheimer's drug from Biogen. Flora Bradley-Watson reports.
Why the newest Alzheimer's drug is controversialCNN’s Elizabeth Cohen reports on the controversy behind the first Alzheimer’s disease treatment approved by the US Food and Drug Administration in 20 years.
![First patient receives Biogen Alzheimer's drug [Video]](https://video.newsserve.net/300/v/20210617/2106170448-First-patient-receives-Biogen-Alzheimer-drug.jpg)
![Why the newest Alzheimer's drug is controversial [Video]](https://video.newsserve.net/300/v/20210607/2106071931-Why-the-newest-Alzheimer-drug-is-controversial.jpg)
